EUVIMEDEUVIMED entdecken
Crossref

Drug repositioning identifies histone deacetylase inhibitors that promote innate immunity in non-tuberculous mycobacterial infection

Adrián Rodriguez-Carlos, Anguita Raúl, Yolanda M Jacobo-Delgado, Carmen Judith Serrano, Alan Santos-Mena, Luis Adrian De Jesus-Gonzalez, Ester Boix, Bruno Rivas-Santiago iD

Canadian Journal of Microbiology · 2024

DOI: 10.1139/cjm-2023-0127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Microbiology, 2024. Verfasst von Adrián Rodriguez-Carlos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Unit-Zacatecas, Mexican Institute for Social Security-IMSS, Zacatecas, Mexico. Hauptthemen laut MEDLINE: Immunity, Innate, Mycobacterium Infections, Nontuberculous, Histone Deacetylase Inhibitors, Cytokines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Consejo Nacional de Ciencia y Tecnologia, Programa Iberoamericano de Ciencia y Tecnología para el Desarrollo, Agencia Estatal de Investigación, Spain.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-tuberculosis infections in immunocompromised patients represent a cause for concern, given the increased risks of infection, and limited treatments available. Herein, we report that molecules for binding to the catalytic site of histone deacetylase (HDAC) inhibit its activity, thus increasing the innate immune response against environmental mycobacteria. The action of HDAC inhibitors (iHDACs) was explored in a model of type II pneumocytes and macrophages infection by Mycobacterium aurum. The results show that the use of 1,3-diphenylurea increases the expression of the TLR-4 in M. aurum infected MDMs, as well as the production of defb4, IL-1β, IL-12, and IL-6. Moreover, we observed that aminoacetanilide upregulates the expression of TLR-4 together with TLR-9, defb4, CAMP, RNase 6, RNase 7, IL-1β, IL-12, and IL-6 in T2P. Results conclude that the tested iHDACs selectively modulate the expression of cytokines and antimicrobial peptides that are associated with reduction of non-tuberculous mycobacteria infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, InnateMycobacterium Infections, NontuberculousHistone Deacetylase InhibitorsCytokinesDrug RepositioningHumansMacrophagesNontuberculous MycobacteriaMycobacterium

Stichwörter der Autor:innen

antimicrobial peptides, cytokineshistone deacetylase inhibitorsnon-tuberculous mycobacteriatoll-like receptors

Substanzen

Histone Deacetylase InhibitorsCytokines

Autor:innen und Institutionen

  • Medical Research Unit-Zacatecas, Mexican Institute for Social Security-IMSS, Zacatecas, Mexico.
  • Department of Biochemistry and Molecular Biology, Faculty of Biosciences, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.

ORCID-Profile: Bruno Rivas-Santiago

Förderung

  • Consejo Nacional de Ciencia y Tecnologia
  • Programa Iberoamericano de Ciencia y Tecnología para el Desarrollo
  • Agencia Estatal de Investigación, Spain

Zitieren

APA

Rodriguez-Carlos, A., Raúl, A., Jacobo-Delgado, Y. M., Serrano, C. J., Santos-Mena, A., De Jesus-Gonzalez, L. A., Boix, E., & Rivas-Santiago, B. (2024). Drug repositioning identifies histone deacetylase inhibitors that promote innate immunity in non-tuberculous mycobacterial infection. Canadian Journal of Microbiology. https://doi.org/10.1139/cjm-2023-0127

Vancouver

Rodriguez-Carlos A, Raúl A, Jacobo-Delgado YM, Serrano CJ, Santos-Mena A, De Jesus-Gonzalez LA, et al. Drug repositioning identifies histone deacetylase inhibitors that promote innate immunity in non-tuberculous mycobacterial infection. Canadian Journal of Microbiology. 2024. doi:10.1139/cjm-2023-0127

BibTeX
@article{RodriguezCarlos2024,
  author = {Rodriguez-Carlos, Adrián and Raúl, Anguita and Jacobo-Delgado, Yolanda M and Serrano, Carmen Judith and Santos-Mena, Alan and De Jesus-Gonzalez, Luis Adrian and Boix, Ester and Rivas-Santiago, Bruno},
  title = {Drug repositioning identifies histone deacetylase inhibitors that promote innate immunity in non-tuberculous mycobacterial infection},
  journal = {Canadian Journal of Microbiology},
  year = {2024},
  doi = {10.1139/cjm-2023-0127}
}
Kostenlos starten →